MRVI Stock: Insider & Congress Trades

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 2 added, 0 cutMore adding

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about MRVI filings

Are insiders buying or selling Maravai Lifesciences Holdings Inc (MRVI) stock?

Neither. Maravai Lifesciences Holdings Inc (MRVI) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded MRVI recently?

None. No member of Congress disclosed a MRVI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MRVI smart-money data?

This summary uses filings available on Oct 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on MRVI

Lean long1 source:
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Kurt Oreshack, sold $254K, scheduled plan sale, filed Jun 10
Lean short · thin1 sale · $254K
1 of 1 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
- Millennium, added +$35.9M, holdings at Jun 30
- JPMorgan Chase, added +$15.5M, holdings at Jun 30
Lean long · thin2 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about MRVI filings

Are insiders buying or selling Maravai Lifesciences Holdings Inc (MRVI) stock?

Neither. Maravai Lifesciences Holdings Inc (MRVI) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded MRVI recently?

None. No member of Congress disclosed a MRVI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MRVI smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$51.5M

Buys/Adds (2)

MI
Millennium
Israel Englander · Q2 2026 13F
$35.9M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
JC
JPMorgan Chase
Q2 2026 13F
$15.5M
added

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 6, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$51.4M

SEC filing

Next report

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 6, 2026	Not on file	No estimate	$51.4MSEC filing	+8.5%from $47.4M
Mar 31, 2026Reported May 7, 2026	$0.01est. -$0.05	+$0.06beat	$65.8MSEC filing	+40.5%from $46.9M
Dec 31, 2025Reported Feb 25, 2026	-$0.04est. -$0.07	+$0.03beat	$185.7M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.08est. -$0.08	+$0.00in line	$41.6MSEC filing	-39.7%from $69.0M
Jun 30, 2025Reported Aug 11, 2025	-$0.08est. -$0.07	-$0.01miss	$47.4MSEC filing	-31.7%from $69.4M
Mar 31, 2025Reported May 12, 2025	-$0.08est. -$0.07	-$0.01miss	$46.9MSEC filing	-27.0%from $64.2M
Dec 31, 2024Reported Mar 18, 2025	-$0.06est. -$0.04	-$0.02miss	$56.6MSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 7, 2024	-$0.02est. -$0.01	-$0.01miss	$69.0MSEC filing	+3.2%from $66.9M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $8.49
52-wk high: $9.42
High: $8.62
52-wk low: $2.55
Low: $8.29
Prev close: $8.50
Mkt cap: $3.15B
ROE: -33.1%
Fwd P/E: 370.4x
Beta: 0.54
P/S: 15.1x
P/B: 6.0x
Profit margin: -37.1%
Op margin: -29.4%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -37.1%
Forward P/E: 370.37
Market cap: $3.1B

Valuation

P/S15.08
P/B6.02

Quality

Operating margin-29.4%
ROE-33.1%
ROA-5.7%

Growth

Beta0.54

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

100 / 100

RSI 14

61balanced

20D volatility

86%annualized

52-week range

$8.46

$2.54$9.42

20D support

$6.33recent floor

20D resistance

$8.74recent ceiling

Returns

5D +19.7%20D +12.8%60D +32.0%

Price vs moving averages

SMA20 +13.3%SMA50 +12.7%SMA200 +62.2%

Volume pace

0.99xvs prior 20D

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 2 added, 0 cutMore adding

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about MRVI filings

Are insiders buying or selling Maravai Lifesciences Holdings Inc (MRVI) stock?

Neither. Maravai Lifesciences Holdings Inc (MRVI) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded MRVI recently?

None. No member of Congress disclosed a MRVI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MRVI smart-money data?

13F: filed up to 45 days late.

Smart money on MRVI

Lean long1 source:
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Kurt Oreshack, sold $254K, scheduled plan sale, filed Jun 10
Lean short · thin1 sale · $254K
1 of 1 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
- Millennium, added +$35.9M, holdings at Jun 30
- JPMorgan Chase, added +$15.5M, holdings at Jun 30
Lean long · thin2 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about MRVI filings

Are insiders buying or selling Maravai Lifesciences Holdings Inc (MRVI) stock?

Neither. Maravai Lifesciences Holdings Inc (MRVI) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded MRVI recently?

None. No member of Congress disclosed a MRVI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MRVI smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$51.5M

Buys/Adds (2)

MI
Millennium
Israel Englander · Q2 2026 13F
$35.9M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
JC
JPMorgan Chase
Q2 2026 13F
$15.5M
added

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 6, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$51.4M

SEC filing

Next report

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 6, 2026	Not on file	No estimate	$51.4MSEC filing	+8.5%from $47.4M
Mar 31, 2026Reported May 7, 2026	$0.01est. -$0.05	+$0.06beat	$65.8MSEC filing	+40.5%from $46.9M
Dec 31, 2025Reported Feb 25, 2026	-$0.04est. -$0.07	+$0.03beat	$185.7M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.08est. -$0.08	+$0.00in line	$41.6MSEC filing	-39.7%from $69.0M
Jun 30, 2025Reported Aug 11, 2025	-$0.08est. -$0.07	-$0.01miss	$47.4MSEC filing	-31.7%from $69.4M
Mar 31, 2025Reported May 12, 2025	-$0.08est. -$0.07	-$0.01miss	$46.9MSEC filing	-27.0%from $64.2M
Dec 31, 2024Reported Mar 18, 2025	-$0.06est. -$0.04	-$0.02miss	$56.6MSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 7, 2024	-$0.02est. -$0.01	-$0.01miss	$69.0MSEC filing	+3.2%from $66.9M

Open: $8.49
52-wk high: $9.42
High: $8.62
52-wk low: $2.55
Low: $8.29
Prev close: $8.50
Mkt cap: $3.15B
ROE: -33.1%
Fwd P/E: 370.4x
Beta: 0.54
P/S: 15.1x
P/B: 6.0x
Profit margin: -37.1%
Op margin: -29.4%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -37.1%
Forward P/E: 370.37
Market cap: $3.1B

Valuation

P/S15.08
P/B6.02

Quality

Operating margin-29.4%
ROE-33.1%
ROA-5.7%

Growth

Beta0.54

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

100 / 100

RSI 14

61balanced

20D volatility

86%annualized

52-week range

$8.46

$2.54$9.42

20D support

$6.33recent floor

20D resistance

$8.74recent ceiling

Returns

5D +19.7%20D +12.8%60D +32.0%

Price vs moving averages

SMA20 +13.3%SMA50 +12.7%SMA200 +62.2%

Volume pace

0.99xvs prior 20D

Maravai Lifesciences Holdings Inc

Smart money at a glance

What do analysts expect?

Questions about MRVI filings

Smart money on MRVI

Questions about MRVI filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Maravai Lifesciences Holdings Inc

Smart money at a glance

What do analysts expect?

Questions about MRVI filings

Smart money on MRVI

Questions about MRVI filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

Estimated report: Nov 4, 2026, in 5 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Maravai Lifesciences Holdings Inc

Overview

Questions about MRVI filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Maravai Lifesciences Holdings Inc

Overview

Questions about MRVI filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.